'It is not fashionable to suffer nowadays': Community motivations to repeatedly participate in outreach HIV testing indicate UHC potential in Tanzania.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2021
2021
Historique:
received:
08
03
2021
accepted:
01
12
2021
entrez:
22
12
2021
pubmed:
23
12
2021
medline:
12
1
2022
Statut:
epublish
Résumé
This study examined people's motivations for (repeatedly) utilizing HIV testing services during community-based testing events in urban and rural Shinyanga, Tanzania and potential implications for Universal Health Coverage (UHC). As part of a broader multidisciplinary study on the implementation of a HIV Test and Treat model in Shinyanga Region, Tanzania, this ethnographic study focused on community-based testing campaigns organised by the implementing partner. Between April 2018 and December 2019, we conducted structured observations (24), short questionnaires (42) and in-depth interviews with HIV-positive (23) and HIV-negative clients (8). Observations focused on motivations for (re-)testing, and the counselling and testing process. Thematic analysis based on inductive and deductive coding was completed using NVivo software. Regular HIV testing was encouraged by counsellors. Most participants in testing campaigns were HIV-negative; 51.1% had tested more than once over their lifetimes. Testing campaigns provided an accessible way to learn one's HIV status. Motivations for repeat testing included: monitoring personal health to achieve (temporary) reassurance, having low levels of trust toward sexual partners, feeling at risk, seeking proof of (ill)-health, and acting responsibly. Repeat testers also associated testing with a desire to start treatment early to preserve a healthy-looking body, should they prove HIV positive. Community-based testing campaigns serve three valuable functions related to HIV prevention and treatment: 1) enable community members to check their HIV status regularly as part of a personalized prevention strategy that reinforces responsible behaviour; 2) identify recently sero-converted clients who would not otherwise be targeted; and 3) engage community with general prevention and care messaging and services. This model could be expanded to include routine management of other (chronic) diseases and provide an entry for scaling up UHC.
Identifiants
pubmed: 34937061
doi: 10.1371/journal.pone.0261408
pii: PONE-D-21-07606
pmc: PMC8694479
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0261408Déclaration de conflit d'intérêts
The Shinyanga and Simiyu Test & Treat program in Tanzania is funded by Gilead Sciences (USA), contract date June 1st 2016. The Amsterdam Institute for Global Health and Development (AIGHD) is a co-recipient of this award. All authors were employed under AIGHD’s auspices. This does not alter our adherence to PLOS ONE policies on sharing data and materials. The funders did not play an active role in study design, data collection, analysis, decision to publish or preparation of the manuscript. All authors declare not to have competing interests.
Références
J Int AIDS Soc. 2019 Jul;22(7):e25366
pubmed: 31321872
Global Health. 2019 Jun 18;15(1):41
pubmed: 31215446
Lancet HIV. 2019 Sep;6(9):e632-e638
pubmed: 31331822
PLoS One. 2019 Feb 22;14(2):e0212343
pubmed: 30794580
Med Anthropol. 2011 Mar;30(2):136-57
pubmed: 21400350
PLoS Med. 2012;9(12):e1001351
pubmed: 23226107
EClinicalMedicine. 2019 May 20;10:10-31
pubmed: 31193863
Lancet Glob Health. 2014 May;2(5):e285-92
pubmed: 24818084
J Int AIDS Soc. 2019 Jul;22 Suppl 3:e25321
pubmed: 31321918
Sex Transm Infect. 2017 Jul;93(Suppl 3):
pubmed: 28736389
BMC Health Serv Res. 2015 Nov 28;15:527
pubmed: 26615587
Health Syst Reform. 2019;5(1):66-77
pubmed: 30924744
PLoS One. 2011 Jan 31;6(1):e16488
pubmed: 21304973
Nature. 2015 Dec 3;528(7580):S77-85
pubmed: 26633769
Lancet HIV. 2016 Mar;3(3):e111-9
pubmed: 26939734
BMC Health Serv Res. 2019 May 20;19(1):317
pubmed: 31109335
PLoS Med. 2016 Aug 16;13(8):e1002083
pubmed: 27529809
AIDS Care. 2016;28 Suppl 3:14-23
pubmed: 27421048